JO
MYOK

John Overdeck’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

John Overdeck’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-146,348
Closed -$14.1M – 3759
2020
Q2 		$14.1M Buy
146,348
+27,345
+23% +$2.28M 0.07% 294
2020
Q1 		$5.58M Buy
119,003
+98,503
+481% +$6.31M 0.05% 456
2019
Q4 		$1.49M Buy
+20,500
New +$1.24M ﹤0.01% 1830
2019
Q3 		– Sell
-21,562
Closed -$1.08M – 3934
2019
Q2 		$1.08M Buy
21,562
+5,962
+38% +$290K ﹤0.01% 1883
2019
Q1 		$811K Buy
+15,600
New +$719K ﹤0.01% 1953
2018
Q1 		– Sell
-15,420
Closed -$649K – 3687
2017
Q4 		$649K Sell
15,420
-74,475
-83% -$2.87M ﹤0.01% 2261
2017
Q3 		$3.85M Buy
+89,895
New +$2.87M 0.01% 928
2016
Q4 		– Sell
-11,879
Closed -$194K – 3653
2016
Q3 		$194K Buy
+11,879
New +$214K ﹤0.01% 2960

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

John Overdeck's MYOK Position: Q3 2020 in Review

John Overdeck sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 146,348 shares — an estimated $14.1M sold.

John Overdeck first reported a position in MYOK in Q3 2016 and held it in 8 quarters. The position peaked at $14.1M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • John Overdeck reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • John Overdeck sold 146,348 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $14.1M.
  • John Overdeck first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 8 quarters.
  • John Overdeck's MyoKardia, Inc. Common Stock position peaked at $14.1M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Two Sigma Investments's 13F filing for Q3 2020, filed 16 Nov 2020.